3-Aminobenzamide

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug Name3-Aminobenzamide
Drug Alias Name3-氨基苯甲酰胺PardexSR-42943-ABINO-1001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPoly (ADP-Ribose) polymerase inhibitors
TargetsPoly (ADP-Ribose) polymerase
Therapy Area/IndicationsPostoperative ComplicationsMyocardial InfarctionHeart Diseases +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaIsrael +[4
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsPostoperative ComplicationsMyocardial InfarctionHeart Diseases +[4

Other Information

ATC CodeN/A
Related LinksN/A